Randomized Controlled Trial of the Gastrin/CCK2 Receptor Antagonist Netazepide in Patients with Barrett's Esophagus

Added 383 days ago (28.04.2021)
Authors: Abrams, J. A., Del Portillo, A., Hills, C., Compres, G., Friedman, R. A., Cheng, B., Poneros, J., Lightdale, C. J., De La Rue, R., di Pietro, M., Fitzgerald, R. C., Sepulveda, A., Wang, T. C.
Read article